For the first time, we were able to demonstrate that a combination of traditional HF marker (NT‐proBNP) with established marker (CYFRA 21‐1) for oncological disease provided a stronger predictive value on clinical outcome than the individual markers were capable of. Here, NPPB is linked to hydrops fetalis.